Zyflo CR is made by Critical Therapeutics, Inc.
Zyflo CR belongs to a group of medications known as leukotriene synthesis inhibitors. Leukotrienes are chemicals produced by the body in response to allergens. These chemicals cause swelling and inflammation in the airways of the lungs and constrict the muscles of the respiratory tract.
Zyflo CR works by inhibiting the production of leukotrienes, which prevents the chemicals from causing
asthma symptoms.
In clinical studies of Zyflo CR for
asthma, people taking the drug had improved breathing and needed to use a "rescue inhaler" less often, compared to those not taking it. This medication was also shown to be safe and effective for treating
asthma in children as young as 12 years old.